Literature DB >> 163727

[The vaso-active intestinal polypeptide in Verner-Morrison syndrome].

F J Seif, P Sadowski, F Heni, R Fischer, S R Bloom, J M Polak.   

Abstract

A 40-year-old man with the Verner-Morrison syndrome (refractory watery diarrhoea and hypokalaemia in islet-cell tumour of the pancreas) had an islet-cell carcinoma of the non-B-cell type with metastases to liver and mesenteric lymph nodes. High concentrations of a vasoactive intestinal polypeptide (VIP) were demonstrated in tumour tissue and plasma by radioimmunological tests. After surgical removal of the tumour the plasma VIP concentration fell to normal. Immunohistochemical tests of the tumour for gastrointestinal hormones demonstrated marked fluorescence only for vaso-active intestinal polypeptide. It is assumed that this polypeptide is largely responsible for the clinical signs. In the described case the severe watery diarrhoea ceased after glucocorticoid administration.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 163727     DOI: 10.1055/s-0028-1106226

Source DB:  PubMed          Journal:  Dtsch Med Wochenschr        ISSN: 0012-0472            Impact factor:   0.628


  5 in total

Review 1.  [The Verner-Morrison syndrome. The clinical picture and pathologic anatomy].

Authors:  A Burkhardt
Journal:  Klin Wochenschr       Date:  1976-01-01

2.  [Diarrhea and islet cell tumor. Clinical and morphological report on 2 observations].

Authors:  A Burkhardt; H Kaess; H Mitschke
Journal:  Klin Wochenschr       Date:  1976-01-01

3.  Effects of vasoactive intestinal polypeptide on intestinal absorption and blood flow.

Authors:  D Mailman
Journal:  J Physiol       Date:  1978-06       Impact factor: 5.182

4.  Prostaglandins E and F in endocrine diarrheagenic syndromes.

Authors:  B M Jaffe; S Condon
Journal:  Ann Surg       Date:  1976-10       Impact factor: 12.969

Review 5.  Prostaglandins and serotonin: nonpeptide diarrheogenic hormones.

Authors:  B M Jaffe
Journal:  World J Surg       Date:  1979-09-20       Impact factor: 3.352

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.